Iris Dorbian
Boston-based Censinet, the third-party risk management company for healthcare providers, has raised $7.8 million in Series A funding. HLM Venture Partners and Cedars-Sinai Health System led the round with participation from seed investors Schooner Capital, LRVHealth and Excelerate Health Ventures.
San Francisco-based Dance Biopharm Holdings Inc, a clinical-stage biopharma company, has raised about $20.5 million in funding. The investors included Molex Ventures LLC, a subsidiary of Koch Industries.
San Francisco-based Harness, a continuous delivery-as-a-service platform, raised $60 million in Series B funding. IVP, Google Ventures and ServiceNow Ventures led the round.
Seattle-based CI Security, a provider of managed detection and response solutions, as well as professional services, has raised $9.6 million in funding. East Seattle Partners led the round.
BlockGen Corp, a newly formed holding company for LendGenuity and Block+Sovrin, has raised an undisclosed amount of Series A funding. Cavatina Capital LLC led the round with participation from Charterhouse Strategic Partners. LendGenuity is a tech software provider for the U.S. mortgage industry while Block+Sorvin is a mortgage blockchain provider.
Zippia, a career resource site, has secured $8.5 million in Series A funding. E.ventures led the round with participation from other investors that included MHS Capital, NextView Ventures and Correlation Ventures. In addition to the funding, Thomas Gieselmann of E.ventures will be joining Zippia's board of directors.
San Francisco-based Fastly Inc, an edge cloud provider, has filed for an IPO. The number of shares that will be sold as well as its pricing terms have yet to be set. Fastly plans on listing the stock on the New York Stock Exchange under the ticker symbol "FSLY." BofA Merrill Lynch, Citigroup and Credit Suisse will serve as the lead underwriters. Fastly's backers include Deutsche Telekom Capital Partners, Sozo Ventures, Sorenson Capital and Swisscom Ventures.
La Jolla, California-based Avidity Biosciences, a biotech company, has secured $15 million in funding as part of a licensing and research agreement with Eli Lilly and Company. According to terms of the deal, Avidity will receive an upfront payment of $20 million and is also eligible to receive up to about $405 million for development, regulatory and commercialization milestones.
Math Venture Partners has raised over $44 million for its second fund, according to an SEC filing. Based in Chicago, the venture firm invests in technology and digital companies.
San Francisco-based PAX Labs Inc., a consumer technology brand, has secured $420 million in financing. The investors included Tiger Global Management and Tao Capital Partners.